文献速递头颈外科小儿耳鼻咽喉

唾液循环肿瘤人乳头瘤病毒DNA检测口咽癌的准确性:系统综述与荟萃分析

Accuracy of Salivary Circulating Tumor Human Papillomavirus DNA in Detecting Oropharyngeal Cancer: A Systematic Review and Meta-Analysis.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2024-01-01

该系统综述与荟萃分析检索Cochrane Library、Embase、PubMed和Web of Science自建库至2023年10月,纳入6项研究共263例患者,评估唾液循环肿瘤人乳头瘤病毒DNA检测人乳头瘤病毒相关口咽癌的准确性,合并敏感度64%(95%CI 36%-85%)、特异度89%(95%CI 46%-99%),SROC曲线AUC为0.80,支持其作为可接受的特异性检测,但需在临床试验中进一步评估后方可实时应用。

要点

  • 唾液循环肿瘤人乳头瘤病毒DNA检测人乳头瘤病毒相关口咽癌的合并敏感度为64%(95%CI 36%-85%)。
  • 合并特异度为89%(95%CI 46%-99%),SROC曲线AUC为0.80。
  • 纳入6项研究共263例患者,异质性中等(I2=36%),偏倚风险低,适用性关注低。

核心结论

  • 本研究支持唾液循环肿瘤人乳头瘤病毒DNA作为一种可接受的特异性检测用于检测人乳头瘤病毒相关口咽癌,但需在临床试验中进一步评估后方可实时应用。

研究设计与样本

  • 系统综述与荟萃分析,检索Cochrane Library、Embase、PubMed和Web of Science数据库自建库至2023年10月,纳入6项研究共263例患者。
  • 纳入标准为所有因可能或已诊断的人乳头瘤病毒相关口咽癌而在就诊时接受唾液循环肿瘤人乳头瘤病毒DNA检测的患者,排除非英文发表和综述类出版物。
  • 两位作者独立投票决定文章纳入,第三位作者解决投票冲突;遵循PRISMA报告指南,多位作者独立提取数据并评估纳入文章的偏倚。
  • 采用双变量随机效应荟萃分析,以I2评估研究异质性;计算敏感度、特异度、阳性似然比、阴性似然比、诊断比值比及其95%CI,以及SROC曲线的AUC。

主要发现

  • 初检 identified 440篇文章,6篇符合纳入标准,异质性中等(I2=36%),偏倚风险低,适用性关注低。
  • 共纳入263例患者,中位(范围)年龄为58(39-86)岁,228例(87%)为男性患者。
  • 按更新预后分期标准,局部肿瘤(即1期或2期)占大多数癌症,为139例(77%),晚期肿瘤(即3期或4期)占其余41例(23%)。
  • 合并敏感度为64%(95%CI 36%-85%),合并特异度为89%(95%CI 46%-99%),合并阳性似然比为11.70(95%CI 0.37-77.00),合并阴性似然比为1.21(95%CI 0.08-7.00),合并诊断比值比为139.00(95%CI 0.05-837.00)。
  • SROC曲线的AUC为0.80。

临床怎么用

  • 原文结论支持唾液循环肿瘤人乳头瘤病毒DNA作为一种可接受的特异性检测用于检测人乳头瘤病毒相关口咽癌,但作者认为需在临床试验中进一步评估后方可实时应用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Circulating tumor human papillomavirus DNA (ctHPV DNA) has shown potential as a biomarker capable of improving outcomes in patients with HPV-related oropharyngeal (OP) cancer. It can be isolated from plasma or saliva, with the latter offering reduced invasiveness and theoretic reduction of lead time. OBJECTIVE: To perform a systematic review and meta-analysis on the accuracy of salivary ctHPV DNA for detecting HPV-associated OP cancer. DATA SOURCES: Cochrane Library, Embase, PubMed, and Web of Science databases were searched from inception through October 2023. STUDY SELECTION: All patients who underwent salivary ctHPV DNA testing at presentation for possible or diagnosed HPV-related OP cancer were included. Non-English and review publications were excluded. Two authors independently voted on article inclusion with a third resolving conflicting votes. DATA EXTRACTION AND SYNTHESIS: Following Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guidelines, multiple authors independently abstracted data and assessed bias of included articles. Bivariate random-effects meta-analysis was performed with I2 to assess for study heterogeneity. MAIN OUTCOMES AND MEASURES: Sensitivities, specificities, positive likelihood ratios (PLR), negative likelihood ratios (NLR), and diagnostic odds ratios (DOR) with 95% CIs alongside area under the curve (AUC) of a summary receiver operating characteristic (SROC) curve were calculated. The initial analysis took place throughout December 2023. RESULTS: Of 440 initially identified articles, 6 met inclusion criteria and demonstrated moderate heterogeneity (I2 = 36%) with low risk of bias and low applicability concerns. Overall, 263 total patients were included with a median (range) age of 58 (39-86) years, and 228 (87%) were male patients. Per updated prognostic staging criteria, localized tumors (ie, stages 1 or 2) comprised most cancers at 139 (77%), whereas advanced ones (ie, stages 3 or 4) comprised the remaining 41 (23%). Pooled sensitivity, specificity, PLR, NLR, and DOR values were 64% (95% CI, 36%-85%), 89% (95% CI, 46%-99%), 11.70 (95% CI, 0.37-77.00), 1.21 (95% CI, 0.08-7.00), and 139.00 (95% CI, 0.05-837.00), respectively. The AUC of the SROC curve was 0.80. CONCLUSIONS AND RELEVANCE: This study supports salivary ctHPV DNA as an acceptably specific test in detecting HPV-associated OP cancer that would benefit from testing in clinical trials prior to real-time implementation.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Lakshmipathy D, Prasad A, Fritz CG, et al. Accuracy of Salivary Circulating Tumor Human Papillomavirus DNA in Detecting Oropharyngeal Cancer: A Systematic Review and Meta-Analysis. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 38780957. doi:10.1001/jamaoto.2024.1067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。